* 'I don't subscribe to the hopeful commentary,' says CEO * Q2 loss/shr $0.90 vs est loss of $0.62 * Says margins expected to improve due... ...http://in.reuters.com/article/baker-hughes-results-idINL4N1AE434
The famous euro sign landmark is photographed outside the former headquarters of the European Central Bank (ECB) in Frankfurt, late evening January... ...http://in.reuters.com/article/eurozone-sentiment-idINKCN1081KN
The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Financial investors seem to think the UK will settle easily... ...http://blogs.reuters.com/breakingviews/2016/07/28/dixon-stock-markets-too-sanguine-about-brexit/
Glaxosmithkline (NYSE:GSK) Intraday Stock Chart Today : Wednesday 27 July 2016 By Denise Roland LONDON--The sharp drop in the value of... ...http://in.advfn.com/p.php?pid=nmona&article=72066284
A major reason for facing loss this quarter has been NPAs, says CR Shashi Kumar , MD, State Bank of Travancore. In an interview with ET Now , Kumar... ...http://economictimes.indiatimes.com/markets/expert-view/npas-a-major-reason-for-incurring-loss-in-the-current-quarter-cr-shashi-kumar-state-bank-of-travancore/articleshow/53411082.cms
Sanguine International is the reputed...